Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies have revealed that
Porphyromonas gingivalis
is closely related to the occurrence and progression of esophageal squamous cell carcinoma (ESCC). However, the underlying mechanism of
P. gingivalis
in ESCC has not been well elucidated. To explore the mechanism of
P. gingivalis
infection in ESCC, cellular proliferation, invasion, and migration models of KYSE-30 and KYSE-150 cells infected by
P. gingivalis
at a multiplicity of infection (MOI) of 10 were established. The results showed that
P. gingivalis
infection could drastically increase the proliferation, invasion, and migration ability of ESCC. Furthermore, the results of high-throughput sequencing showed that miR-194 was considerably upregulated in infected cells compared with control cells, which was further verified by qRT-PCR. The inhibition or overexpression of miR-194 had a significant effect on KYSE-30 and KYSE-150 cell migration and invasion. Additionally, the levels of
GRHL3
and PTEN were decreased in
P. gingivalis
-infected esophageal cancer cells compared with uninfected esophageal cancer cells. Furthermore, dual-luciferase experiments confirmed that
GRHL3
is a direct target of miR-194. In addition, the
GRHL3
-related pathway was investigated, and the levels of
GRHL3
and PTEN were downregulated while the level of p-Akt was upregulated after
P. gingivalis
infection. Taken together, these findings indicated that
P. gingivalis
might promote ESCC proliferation and migration via the miR-194/
GRHL3
/PTEN/Akt signaling axis.
ACS
Infect Dis 2020 05 08
PMID:
Porphyromonas gingivalis
Promotes the Proliferation and Migration of Esophageal Squamous Cell Carcinoma through the miR-194/GRHL3/PTEN/Akt Axis. 3229 82